Efficacy and Safety of Mizolastine in Seasonal Allergic Rhinitis
Authors:
- Margarita MurrietaMMMargarita Murrieta
- 1 February 1996
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 76 (2) , 163-168
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteersEuropean Journal of Clinical Pharmacology, 1994
- Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjectsInternational Clinical Psychopharmacology, 1994
- Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.British Journal of Clinical Pharmacology, 1992
- Anti-anaphylactic activity of the non sedative histamime H1 receptor antagonist SL 85.0324 in the rat and guinea pigEuropean Journal of Pharmacology, 1990
- CNS-pharmacodynamics and pharmacokinetics of the new non-sedative H1-antagonist SL 85.0324 vs placebo and dimetinden in volunteersEuropean Journal of Pharmacology, 1990
- SL 85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist propertiesEuropean Journal of Pharmacology, 1990
- Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1989